PureTech Health plc
PRTCNASDAQHealthcare● Active
$17.42
+$0.17(+0.99%)
Market Cap$424066836
P/E Ratio—
52W High$19.92
52W Low$14.5
PureTech Health plc (PRTC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PRTC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
-$26.90
Est. -$1.94 · -1286.6%
Revenue
$0.00B
Est. $0.00B · +47.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
PRTC reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 27, 2026 | -$1.16 | — | — | — | $0.02B | — |
| ▼ Q2 FY2026 | Apr 29, 2026 | -$1.94 | -$26.90 | -1286.6% | $0.00B | $0.00B | +47.2% |
| ▲ Q3 FY2025 | Aug 28, 2025 | -$2.04 | -$1.86 | +8.9% | $0.00B | $0.03B | -93.2% |
| ▲ Q2 FY2025 | Apr 30, 2025 | -$2.83 | $0.35 | +112.5% | $0.00B | $0.03B | -86.7% |
| ▲ Q3 FY2024 | Aug 28, 2024 | -$3.03 | -$0.15 | +94.9% | $0.00B | $0.01B | -96.2% |
| ▲ Q2 FY2024 | Apr 25, 2024 | -$3.25 | -$0.15 | +95.5% | $0.00B | $0.01B | -97.0% |
| ▼ Q2 FY2023 | Apr 28, 2023 | $0.34 | -$0.08 | -124.1% | $0.01B | $0.01B | +15.5% |
| ▲ Q3 FY2022 | Aug 25, 2022 | -$2.75 | -$0.10 | +96.4% | $0.01B | $0.01B | -13.1% |
Q3 FY2026
Aug 27, 2026
EPS Actual
—
EPS Est.
-$1.16
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Miss
EPS Actual
-$26.90
EPS Est.
-$1.94
EPS Surpr.
-1286.6%
Revenue
$0.00B
Q3 FY2025
Aug 28, 2025Beat
EPS Actual
-$1.86
EPS Est.
-$2.04
EPS Surpr.
+8.9%
Revenue
$0.00B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
$0.35
EPS Est.
-$2.83
EPS Surpr.
+112.5%
Revenue
$0.00B
Q3 FY2024
Aug 28, 2024Beat
EPS Actual
-$0.15
EPS Est.
-$3.03
EPS Surpr.
+94.9%
Revenue
$0.00B
Q2 FY2024
Apr 25, 2024Beat
EPS Actual
-$0.15
EPS Est.
-$3.25
EPS Surpr.
+95.5%
Revenue
$0.00B
Q2 FY2023
Apr 28, 2023Miss
EPS Actual
-$0.08
EPS Est.
$0.34
EPS Surpr.
-124.1%
Revenue
$0.01B
Q3 FY2022
Aug 25, 2022Beat
EPS Actual
-$0.10
EPS Est.
-$2.75
EPS Surpr.
+96.4%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-1.94 | $-1.94 | $-1.94 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $-2.04 | $-2.04 | $-2.04 | 1 |
| Q2 FY2024 | $-3.03 | $-3.03 | $-3.03 | 1 |
| Q4 FY2023 | $-3.25 | $-3.25 | $-3.25 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 29, 2026 | -1286.6% | $18.14 | $17.40 | -4.08% |
| ▲ Q3 FY2025 | Aug 28, 2025 | +8.9% | $18.01 | $17.35 | -3.66% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +112.5% | $17.50 | $17.26 | -1.37% |
| ▲ Q3 FY2024 | Aug 28, 2024 | +94.9% | $25.00 | $23.50 | -6.00% |
| ▲ Q2 FY2024 | Apr 25, 2024 | +95.5% | $27.48 | $28.50 | +3.71% |
| ▼ Q2 FY2023 | Apr 28, 2023 | -124.1% | $25.75 | $25.75 | +0.00% |
| ▲ Q3 FY2022 | Aug 25, 2022 | +96.4% | $29.74 | $30.50 | +2.56% |
| ▲ Q2 FY2022 | Apr 21, 2022 | +102.1% | $25.08 | $25.61 | +2.11% |
Q2 FY2026-4.08%
Report Date
Apr 29, 2026
EPS Beat/Miss
-1286.6%
Price Before
$18.14
Price After
$17.40
Q3 FY2025-3.66%
Report Date
Aug 28, 2025
EPS Beat/Miss
+8.9%
Price Before
$18.01
Price After
$17.35
Q2 FY2025-1.37%
Report Date
Apr 30, 2025
EPS Beat/Miss
+112.5%
Price Before
$17.50
Price After
$17.26
Q3 FY2024-6.00%
Report Date
Aug 28, 2024
EPS Beat/Miss
+94.9%
Price Before
$25.00
Price After
$23.50
Q2 FY2024+3.71%
Report Date
Apr 25, 2024
EPS Beat/Miss
+95.5%
Price Before
$27.48
Price After
$28.50
Q2 FY2023+0.00%
Report Date
Apr 28, 2023
EPS Beat/Miss
-124.1%
Price Before
$25.75
Price After
$25.75
Q3 FY2022+2.56%
Report Date
Aug 25, 2022
EPS Beat/Miss
+96.4%
Price Before
$29.74
Price After
$30.50
Q2 FY2022+2.11%
Report Date
Apr 21, 2022
EPS Beat/Miss
+102.1%
Price Before
$25.08
Price After
$25.61
Avg Beat Reaction-0.44%
Avg Miss Reaction-2.04%
Beat Rate6 / 8 quarters
Largest Move-6.00% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PRTC ends December
PureTech Health plc (PRTC) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $-26.90 — missing the analyst consensus of $-1.94 by -1286.6%. The next PRTC earnings date is expected around September 1, 2026.
Each quarter, investors track PRTC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PRTC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PRTC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PRTC earnings · 5 questionsPureTech Health plc's next earnings report is expected around September 1, 2026. PRTC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PRTC historically reports after market close (AMC).
PRTC earnings datewhen is PRTC earningsPRTC next earnings datewhen does PRTC report earningsPRTC earnings calendar
▸ Source: FMP · PureTech Health plc SEC filings · US GAAP · PureTech Health plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026